批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2021/08/20 |
SUPPL-34(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/08/20 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/11/30 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/11/30 |
SUPPL-30(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/05/30 |
SUPPL-29(补充) |
Approval |
REMS |
N/A
|
|
|
2019/05/10 |
SUPPL-27(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/10/25 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/05/11 |
SUPPL-23(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2015/04/09 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/06/19 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/05/01 |
SUPPL-20(补充) |
Approval |
REMS |
N/A
|
|
|
2014/01/02 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/08/30 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/11/22 |
SUPPL-14(补充) |
Approval |
REMS |
N/A
|
|
|
2009/09/18 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/10/31 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:TESTOSTERONE 剂型/给药途径:GEL;TRANSDERMAL 规格:50MG/5GM PACKET 治疗等效代码:AB2
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021454 |
001 |
NDA |
TESTIM |
TESTOSTERONE |
GEL;TRANSDERMAL |
50MG/5GM PACKET |
Prescription |
Yes |
Yes |
AB2 |
2002/10/31
|
ENDO OPERATIONS |
204399 |
002 |
NDA |
VOGELXO |
TESTOSTERONE |
GEL;TRANSDERMAL |
50MG/5GM PACKET |
Prescription |
No |
No |
AB2 |
2014/06/04
|
UPSHER SMITH LABS |
091073 |
001 |
ANDA |
TESTOSTERONE |
TESTOSTERONE |
GEL;TRANSDERMAL |
50MG/5GM PACKET |
Prescription |
No |
No |
AB2 |
2017/09/18
|
ACTAVIS LABS UT INC |